Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beom Jun Kim

Showing results (261-270 of 270) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 270 results.
Journal of the Korean Association of Oral and Maxillofacial Surgeons|December 30, 2025
Medication-related osteonecrosis of the jaw: an evidence-based 2025 position statement from a Korean multidisciplinary task forceJin-Woo Kim, Sung-Hye Kong, Jae-Young Kim, et al.
Cell Reports. Medicine|August 1, 2025
Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancerMatthew V Holt, Yongchao Dou, Meggie N Young, et al.
Plos One|October 16, 2010
European bone mineral density loci are also associated with BMD in East-Asian populationsUnnur Styrkarsdottir, Bjarni V Halldorsson, Daniel F Gudbjartsson, et al.
Cell Reports. Medicine|June 6, 2025
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkersEric J Jaehnig, Aranzazu Fernandez-Martinez, Tanmayi D Vashist, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancerJorge Gomez Tejeda Zanudo, Busem Binboga Kurt, Allison Frangieh, et al.
Cancer Cell|March 7, 2020
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast CancerZe-Yi Zheng, Meenakshi Anurag, Jonathan T Lei, et al.
Nature Communications|January 29, 2020
Microscaled proteogenomic methods for precision oncologyShankha Satpathy, Eric J Jaehnig, Karsten Krug, et al.
Journal of Medical Genetics|January 26, 2013
Meta-analysis identifies a MECOM gene as a novel predisposing factor of osteoporotic fractureJoo-Yeon Hwang, Seung Hun Lee, Min Jin Go, et al.
Cancer Discovery|August 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Eric J Jaehnig, Karsten Krug, et al.
Cancer Discovery|August 8, 2025
Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancerNicholas J Neill, Shankha Satpathy, Karsten Krug, et al.
Pageof 27

Showing results (261-270 of 270) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
Journal of the Korean Association of Oral and Maxillofacial Surgeons|December 30, 2025
Medication-related osteonecrosis of the jaw: an evidence-based 2025 position statement from a Korean multidisciplinary task forceJin-Woo Kim, Sung-Hye Kong, Jae-Young Kim, et al.
Cell Reports. Medicine|August 1, 2025
Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancerMatthew V Holt, Yongchao Dou, Meggie N Young, et al.
Plos One|October 16, 2010
European bone mineral density loci are also associated with BMD in East-Asian populationsUnnur Styrkarsdottir, Bjarni V Halldorsson, Daniel F Gudbjartsson, et al.
Cell Reports. Medicine|June 6, 2025
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkersEric J Jaehnig, Aranzazu Fernandez-Martinez, Tanmayi D Vashist, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancerJorge Gomez Tejeda Zanudo, Busem Binboga Kurt, Allison Frangieh, et al.
Cancer Cell|March 7, 2020
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast CancerZe-Yi Zheng, Meenakshi Anurag, Jonathan T Lei, et al.
Nature Communications|January 29, 2020
Microscaled proteogenomic methods for precision oncologyShankha Satpathy, Eric J Jaehnig, Karsten Krug, et al.
Journal of Medical Genetics|January 26, 2013
Meta-analysis identifies a MECOM gene as a novel predisposing factor of osteoporotic fractureJoo-Yeon Hwang, Seung Hun Lee, Min Jin Go, et al.
Cancer Discovery|August 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Eric J Jaehnig, Karsten Krug, et al.
Cancer Discovery|August 8, 2025
Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancerNicholas J Neill, Shankha Satpathy, Karsten Krug, et al.
Pageof 27